Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

Blue light can illuminate areas affected by diabetic retinopathy

Blue light can illuminate areas affected by diabetic retinopathy

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

Study: Youth with type1 diabetes who use insulin pumps less likely to develop diabetic retinopathy

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

Researchers develop new exosome formulation to deliver VEGF antibodies for synergistic therapy

New biomarkers in the eyes could unlock the key to management of diabetic retinopathy

New biomarkers in the eyes could unlock the key to management of diabetic retinopathy

Study sheds new light on the function of a sight-saving growth factor

Study sheds new light on the function of a sight-saving growth factor

New mathematical model helps simulate progression of age-related macular degeneration

New mathematical model helps simulate progression of age-related macular degeneration

AI could predict treatment demand for chronic eye diseases

AI could predict treatment demand for chronic eye diseases

Weight loss drug Wegovy approved by FDA

Weight loss drug Wegovy approved by FDA

New resolution urges Member States to focus on prevention and management of  diabetes, obesity

New resolution urges Member States to focus on prevention and management of diabetes, obesity

Researchers identify new targets to control angiogenesis

Researchers identify new targets to control angiogenesis

Early treatment with anti-VEGF injections slows diabetic retinopathy

Early treatment with anti-VEGF injections slows diabetic retinopathy

New AI platform can help assess vascular diseases

New AI platform can help assess vascular diseases

New study aims to develop alternative treatment for posterior eye diseases

New study aims to develop alternative treatment for posterior eye diseases

A sneak peek of the current state and future use of artificial intelligence in pathology

A sneak peek of the current state and future use of artificial intelligence in pathology

Smartphones could be used to reveal early-warning signs of glaucoma

Smartphones could be used to reveal early-warning signs of glaucoma

Scientists find new therapeutic approach to effectively treat age-related macular degeneration

Scientists find new therapeutic approach to effectively treat age-related macular degeneration

New method can help evaluate potential sight-preserving properties

New method can help evaluate potential sight-preserving properties

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

AI screening algorithms to diagnose diabetic retinopathy do not show consistent performance

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes

Routine eye imaging may provide clues to cognitive disorders in older people with type 1 diabetes